Nonalcoholic fatty liver disease: is it all in the genes?
Dawn McDowell Torres, Stephen A. Harrison – 29 October 2010
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1
Salvatore Petta, Marco Amato, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Carla Giordano, Aldo Galluzzo, Antonio Craxì – 29 October 2010 – Metabolic factors have been associated with liver damage in patients with genotype 1 chronic hepatitis C (G1 CHC). We tested visceral adiposity index (VAI), a new marker of adipose dysfunction in G1 CHC, patients to assess its association with host and viral factors and its link to both histological findings and sustained virological response (SVR).
Differences in portal hemodynamics between whole liver transplantation and living donor liver transplantation
Shui‐Ming Jiang, Qi‐Shun Zhang, Guang‐Wen Zhou, Shi‐Feng Huang, Hai‐Ming Lu, Cheng‐Hong Peng – 28 October 2010 – The aim of this study was to investigate the differences in portal hemodynamics between whole liver transplantation and living donor liver transplantation (LDLT). Twenty patients who underwent LDLT (the L group) and 42 patients who underwent whole liver transplantation (the W group) were enrolled, and colored Doppler ultrasonography was performed preoperatively and on postoperative days (PODs) 1, 3, 5, 7, 30, and 90.
Inhibition of inducible nitric oxide synthase prevents graft injury after transplantation of livers from rats after cardiac death
Yanjun Shi, Hasibur Rehman, Gary L. Wright, Zhi Zhong – 28 October 2010 – This study investigated the roles of inducible nitric oxide synthase (iNOS) in the failure of rat liver grafts from cardiac death donors (GCDD). Livers were explanted after 30‐minute aorta clamping and implanted after 4‐hour storage in University of Wisconsin solution. The iNOS expression increased slightly in grafts from non–cardiac death donors (GNCDD) but markedly in GCDD.
Reversal of hepatic myelopathy after liver transplantation: Fifteen plus one
Umberto Baccarani, Erika Zola, Gian Luigi Adani, Matteo Cavalletti, Sami Schiff, Annachiara Cagnin, Carlo Poci, Carlo Merkel, Piero Amodio, Sara Montagnese – 28 October 2010
Moderate ascites identifies patients with low model for end‐stage liver disease scores awaiting liver transplantation who have a high mortality risk
Ma Somsouk, Rachel Kornfield, Eric Vittinghoff, John M. Inadomi, Scott W. Biggins – 28 October 2010 – Donor livers are offered to patients with the highest risk of death. How ascites could inform risk models to reduce liver transplant wait‐list mortality is unclear. All adult candidates for primary liver transplantation for cirrhosis without exception points who were registered with the Organ Procurement and Transplantation Network from 2005 to 2007 composed our study cohort.
Overestimating the liver volume for subjects with low body weight
See Ching Chan, Chung Mau Lo, Sheung Tat Fan – 28 October 2010
Hypomagnesemia and the risk of new‐onset diabetes after liver transplantation
Steven Van Laecke, Federico Desideri, Anja Geerts, Hans Van Vlierberghe, Frederik Berrevoet, Xavier Rogiers, Roberto Troisi, Bernard de Hemptinne, Raymond Vanholder, Isabelle Colle – 28 October 2010 – New‐onset diabetes after transplantation (NODAT) is a frequent complication after liver transplantation and has a negative impact on both patient and graft survival.
Reply
Norman M. Kneteman, Toshiyasu Kawahara – 28 October 2010
Reply
Mahmoud Abu‐Amara, Shiyu Yang, Niteen Tapuria, Barry J. Fuller, Brian R. Davidson, Alexander M. Seifalian – 28 October 2010